A Phase 1/1b Study of the All-Oral Regimen CC-486 and Venetoclax in Acute Myeloid Leukemia

Blood Advances · Published 2026-07-24 · DOI 10.1182/bloodadvances.2026020179

Free full text

Authors (17)

Maria L Amaya, Diana Abbott, Christine M. McMahon, Marc S. Schwartz, Jonathan A Gutman, Andrew Kent, Mathew G. Angelos, Connor Sohalski, Ayele Belachew, Jessica Dell-Martin, Katelyn Anttila, Brett M. Stevens, Angelo D'Alessandro, William M Showers, Austin E Gillen, Craig T. Jordan, Daniel A. Pollyea

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Amaya, M., Abbott, D., McMahon, C., et al. (2026). A Phase 1/1b Study of the All-Oral Regimen CC-486 and Venetoclax in Acute Myeloid Leukemia. Blood Advances. https://doi.org/10.1182/bloodadvances.2026020179

Related articles

• Long-term experience with emicizumab in people with hemophilia A in the Canadian Bleeding Disorders Registry · Blood Advances · 2026 · Same journal
• Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development · Blood Advances · 2026 · Same journal
• Incidence and clinical impact of absolute lymphocyte count-only progression in chronic lymphocytic leukemia · Blood Advances · 2026 · Same journal
• Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q · Blood Advances · 2026 · Same journal
• Reframing Hematologic and Thrombovascular Care for Transgender and Gender-Diverse Individuals: A Scoping Review · Blood Advances · 2026 · Same journal
• Frequency, kinetics, and clinical significance of HHV-6 DNAemia after PTCy-based hematopoietic cell transplant · Blood Advances · 2026 · Same journal
• Optimizing outcomes and accessibility of matched sibling donor transplant for transfusion dependent thalassemia in LMICs · Blood Advances · 2026 · Same journal
• The zebrafish model tackles anti-P2Y12 variability in humans: a translational approach · Blood Advances · 2026 · Same journal
• In vivo and ex vivo impact of THBD and PROCR polymorphisms on the anticoagulant response of the protein C pathway · Blood Advances · 2026 · Same journal
• JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow Transplantation · Blood Advances · 2026 · Same journal